GRAFAPEX
Active substance: treosulfan
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TREOSULFAN 1000 mg/g
United StatesActive
Marketing holder: Medexus Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- TREOSULFAN · 1000 mg/g
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-519d-71e5-a741-da8ec7930bc5,01a120c3-53d8-7f11-abfb-80190e2781d7,01a120c4-ca62-76dd-a49b-611ff7674c1e,01a120c5-f877-7914-8577-3868e53e05f3,01a120c6-dc66-7638-905d-50e452aa0c1d;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-899e-756e-80cc-7fd3ca333dd9,01a1209b-54de-7572-9dac-b7950405b0da;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59137-335
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 59137-335 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59137-335 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59137-335 · Verified 2026-10-09 · open in source